drugset / Trial / NCT06005207

Vaginal Progesterone Improves Clinical Outcomes of RIF Patients

NCT06005207

Unknown 152 enrolled Nanjing University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a single-center, randomized, controlled prospective study. Those patients with repeated implantation failure (RIF) who will recieve frozen thawed embryo transfer (FET) are enrolled in the study. To determine the effect of vaginal progesterone on the clinical pregnancy outcomes of RIF patients.

Timeline

Start
2023-08-01
Primary completion
2024-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 90 mg Other

Indications